GLP-1 therapy is worth sticking with
Both Novo Nordisk (manufacturer of Wegovy and Ozempic ) and Eli Lilly (manufacturer of Zepbound and Mounjaro ) maintain active pregnancy exposure registries to track maternal and fetal outcomes
4,18-22,37 Recent meta-analyses of data from the GLP-1RA CVOTs (representing some of the largest and longest-duration studies with these agents), including PIONEER 6, have not identified an increased risk of pancreatitis
Baseline HbA1c levels were also higher in the dulaglutide group (7.34 0.89 vs
To view or add a comment, sign in Another publication from our group showing the additional renoprotective effects of sodiumglucose co-transporter 2 inhibitors (SGLT2is) as an adjunct to glucagon-like peptide-1 receptor agonists (GLP-1 RAs)
Its a targeted, scalable solution for weight and metabolic health, built to plug into what your company already provides